Discontinuation report GLYXAMBI
Report ID | 139877 |
Drug Identification Number | 02459760 |
Brand name | GLYXAMBI |
Common or Proper name | GLYXAMBI 25/5MG 3X10S |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LINAGLIPTIN EMPAGLIFLOZIN |
Strength(s) | 5MG 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 3X10 BLISTER PACK |
ATC code | A10BD |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-12-15 |
Actual discontinuation date | 2021-12-09 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Inventory depleted |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2021-12-10 | English | Compare |
v14 | 2021-12-09 | French | Compare |
v13 | 2021-12-09 | English | Compare |
v12 | 2021-11-11 | French | Compare |
v11 | 2021-11-11 | English | Compare |
v10 | 2021-10-29 | French | Compare |
v9 | 2021-10-29 | English | Compare |
v8 | 2021-10-07 | French | Compare |
v7 | 2021-10-07 | English | Compare |
v6 | 2021-09-17 | French | Compare |
v5 | 2021-09-17 | English | Compare |
v4 | 2021-08-19 | French | Compare |
v3 | 2021-08-19 | English | Compare |
v2 | 2021-05-25 | French | Compare |
v1 | 2021-05-25 | English | Compare |
Showing 1 to 15 of 15